FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation
The U.S. Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the …
Read More